{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rhinitis%2C+Allergic%2C+Seasonal&page=4", "query": { "condition": "Rhinitis, Allergic, Seasonal", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 128, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rhinitis%2C+Allergic%2C+Seasonal&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rhinitis%2C+Allergic%2C+Seasonal&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T19:34:52.655Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00917111", "title": "The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Nasal CO2", "type": "DRUG" }, { "name": "Inactive Placebo Gas", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Capnia, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 33, "start_date": "2009-07", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2012-08-15", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00917111" }, { "nct_id": "NCT02582073", "title": "Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Placebo (0.5ml)", "type": "BIOLOGICAL" }, { "name": "Placebo (1.0ml)", "type": "BIOLOGICAL" }, { "name": "Grass MATA MPL (0.5ml) 5100SU", "type": "BIOLOGICAL" }, { "name": "Grass MATA MPL (1.0ml) 10200SU", "type": "BIOLOGICAL" }, { "name": "Grass MATA MPL (1.0ml) 18200SU", "type": "BIOLOGICAL" }, { "name": "Grass MATA (0.5ml) 5100SU", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Allergy Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 265, "start_date": "2015-11-07", "completion_date": "2017-04-28", "has_results": false, "last_update_posted_date": "2021-01-29", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 1, "location_summary": "Neptune City, New Jersey", "locations": [ { "city": "Neptune City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02582073" }, { "nct_id": "NCT01850823", "title": "Clinical Equivalence Study of Mometasone Nasal Spray", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "Mometasone nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 880, "start_date": "2013-02", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2020-08-19", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 25, "location_summary": "Stockbridge, Georgia • Louisville, Kentucky • Bethesda, Maryland + 17 more", "locations": [ { "city": "Stockbridge", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01850823" }, { "nct_id": "NCT00296530", "title": "Study Of Patients With Allergic Rhinitis And Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "montelukast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 600, "start_date": "2005-09", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 80, "location_summary": "Ozark, Alabama • Tempe, Arizona • Little Rock, Arkansas + 67 more", "locations": [ { "city": "Ozark", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00296530" }, { "nct_id": "NCT00689299", "title": "Phase 2 Study in Adults Sensitized to Cat", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergy" ], "interventions": [ { "name": "Standardized Allergenic Extract, Cat Hair", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Antigen Laboratories, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 167, "start_date": "2008-10", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2014-05-01", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 3, "location_summary": "San Diego, California • Marietta, Georgia • St Louis, Missouri", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Marietta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00689299" }, { "nct_id": "NCT00117832", "title": "Nasal Ocular Reflexes Contribute to Eye Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rhinitis, Allergic, Seasonal" ], "interventions": [ { "name": "Azelastine nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 20, "start_date": "2005-03", "completion_date": "2006-10", "has_results": false, "last_update_posted_date": "2013-09-05", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00117832" }, { "nct_id": "NCT01578278", "title": "Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Bepotastine besilate formulation", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Bepotastine besilate-fluticasone propionate", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 606, "start_date": "2011-12", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2020-10-05", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 1, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01578278" }, { "nct_id": "NCT01307319", "title": "Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis", "SAR" ], "interventions": [ { "name": "BDP HFA", "type": "DRUG" }, { "name": "Placebo nasal aerosol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 715, "start_date": "2011-03", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2015-02-20", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 45, "location_summary": "Oxford, Alabama • Bell, California • Costa Mesa, California + 40 more", "locations": [ { "city": "Oxford", "state": "Alabama" }, { "city": "Bell", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307319" }, { "nct_id": "NCT01279057", "title": "A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Seasonal" ], "interventions": [ { "name": "Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)", "type": "DRUG" }, { "name": "Fluticasone furoate (Veramyst®) 27.5 mcg/actuation nasal spray", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 727, "start_date": "2010-12-27", "completion_date": "2011-02-08", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 7, "location_summary": "Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Kerrville", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01279057" }, { "nct_id": "NCT02318303", "title": "To Study GSP 301 in Patients With Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "GSP 301-1 NS (QD)", "type": "DRUG" }, { "name": "GSP 301-2 NS (BID)", "type": "DRUG" }, { "name": "GSP 301 Placebo NS", "type": "DRUG" }, { "name": "Olopatadine HCl-1 NS (QD)", "type": "DRUG" }, { "name": "Olopatadine HCl-2 NS (BID)", "type": "DRUG" }, { "name": "Mometasone Furoate-1 NS (QD)", "type": "DRUG" }, { "name": "Mometasone Furoate-2 NS (BID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Pharmaceuticals Ltd. India", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1111, "start_date": "2014-12", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2020-10-20", "last_synced_at": "2026-10-09T19:34:52.655Z", "location_count": 10, "location_summary": "Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Kerrville", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02318303" } ] }